Reggie Kelly

Reggie Kelly currently serves as Vice President Development and Dublin Site Head at Gilead Sciences, where responsibilities include overseeing global clinical operations and oncology clinical operations since joining the company in October 2012. Prior to Gilead, Reggie held the position of Director Global Study Management at Amgen from January 2003 to September 2012, managing global clinical development programs for various drugs. Reggie's career began as Vice President of North American Operations at Chiltern International, where significant growth was achieved from a small team to over 70 employees across multiple U.S. locations from January 1999 to January 2003. Reggie holds a Bachelor of Arts in Biology from Duke University, obtained between 1984 and 1988.